Immature articular cartilage is more susceptible to blood-induced damage than mature articular cartilage: An in vivo animal study

Arthritis and Rheumatism

Volumn 48, Issue 2, 2003, Pages 396-403

  Hooiveld, Michel J J ^a   Roosendaal, Goris ^a   Vianen, Marieke E ^a   Van den Berg, H Marijke ^a   Bijlsma, Johannes W J ^a   Lafeber, Floris P J G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEOGLYCAN;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARTILAGE; CARTILAGE DEGENERATION; CATABOLISM; DOG; FEMALE; HEMARTHROSIS; HISTOLOGY; INFLAMMATION; MATURATION; NONHUMAN; PRIORITY JOURNAL; PROTEOGLYCAN SYNTHESIS; SYNOVITIS;

AGE FACTORS; ANIMALS; BLOOD; CARTILAGE, ARTICULAR; DOGS; FEMALE; HEMORRHAGE; INJECTIONS, INTRA-ARTICULAR; KNEE JOINT; PROTEOGLYCANS; SYNOVIAL MEMBRANE;

EID: 0037331212     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10769     Document Type: Article

References (24)

1. Arnold WD, Hilgartner MW. Hemophilic arthropathy: current concepts of pathogenesis and management. J Bone Joint Surg Am 1977;59:287-305.
2. Roosendaal G, Vianen ME, van den Berg HM, Lafeber FP, Bijlsma JW. Cartilage damage as a result of hemarthrosis in a human in vitro model. J Rheumatol 1997;24:1350-4.
3. Roosendaal G, Vianen ME, Marx JJM, van den Berg HM, Lafeber FPJG, Bijlsma JWJ. Blood-induced joint damage: a human in vitro study. Arthritis Rheum 1999;42:1025-32.
4. Roosendaal G, TeKoppele JM, Vianen ME, van den Berg HM, Lafeber FPJG, Bijlsma JWJ. Blood-induced joint damage: a canine in vivo study. Arthritis Rheum 1999;42:1033-9.
5. Roosendaal G, van Rinsum AC, Vianen ME, van den Berg HM, Lafeber FP, Bijlsma JW. Haemophilic arthropathy resembles degenerative rather than inflammatory joint disease. Histopathology 1999;34:144-53.
6. Roosendaal G, TeKoppele JM, Vianen ME, van den Berg HM, Lafeber FP, Bijlsma JW. Articular cartilage is more susceptible to blood induced damage at young than at old age. J Rheumatol 2000;27:1740-4.
7. Fischer K, van der Bom JG, Mauser-Bunschoten EP, Roosendaal G, Prejs R, de Kleijn P, et al. The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia. Blood 2002;99:2337-41.
8. Smith PS, Teutsch SM, Shaffer PA, Rolka H, Evatt B. Episodic versus prophylactic infusions for hemophilia A: a cost-effectiveness analysis. J Pediatr 1996;129:424-31.
9. Fischer K. Treatment strategies for severe haemophilia [dissertation]. Utrecht (The Netherlands): Utrecht Univ.; 2001.
10. DeGroot J. AGEs in the development of osteoarthritis: cartilage synthesis and degradation [dissertation]. Utrecht (The Netherlands): Utrecht Univ.; 2001.
11. Mankin HJ, Dorfman H, Lippiello L, Zarins A. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am 1971;53:523-37.
12. Lafeber FP, van der Kraan PM, van Roy JL, Huber-Bruning O, Bijlsina JW. Articular cartilage explant culture: an appropriate in vitro system to compare osteoarthritic and normal human cartilage. Connect Tissue Res 1993;29:287-99.
13. Marijnissen AC, van Roermund PM, TeKoppele JM, Bijlsma JW, Lafeber FP. The canine 'groove' model, compared with the ACLT model of osteoarthritis. Osteoarthritis Cartilage 2002;10:145-55.
14. Goldenberg DL, Cohen AS. Synovial membrane histopathology in the differential diagnosis of rheumatoid arthritis, gout, pseudogout, systemic lupus erythematosus, infectious arthritis and degenerative joint disease. Medicine (Baltimore) 1978;57:239-52.
15. DeGroot J, Verzijl N, Bank RA, Lafeber FPJG, Bijlsma JWJ, TeKoppele JM. Age-related decrease in proteoglycan synthesis of human articular chondrocytes: the role of nonenzymatic glycation. Arthritis Rheum 1999;42:1003-9.
16. DeGroot J, Verzijl N, Wenting-Van Wijk MJG, Bank RA, Lafeber FPJG, Bijlsma JWJ, et al. Age-related decrease in susceptibility of human articular cartilage to matrix metalloproteinase-mediated degradation: the role of advanced glycation end products. Arthritis Rheum 2001;44:2562-71.
17. Verbruggen G, Cornelissen M, Almqvist KF, Wang L, Elewaut D, Broddelez C, et al. Influence of aging on the synthesis and morphology of the aggrecans synthesized by differentiated human articular chondrocytes. Osteoarthritis Cartilage 2000;8:170-9.
18. Hooiveld M, Roosendaal G, Wenting M, van de Berg M, Bijlsma J, Lafeber F. Short term exposure of cartilage to blood results in chondrocyte apoptosis. Am J Pathol. In press.
19. Buckwalter JA, Mankin HJ. Articular cartilage: tissue design and chondrocyte-matrix interactions. Instr Course Lect 1998;47:477-86.
20. Lafeber FP, van der Kraan PM, van Roy JL, Vitters EL, Huber-Bruning O, van den Berg WB, et al. Local changes in proteoglycan synthesis during culture are different for normal and osteoarthritic cartilage. Am J Pathol 1992;140:1421-9.
21. Nagase H, Woessner JF Jr. Role of endogenous proteinases in the degradation of cartilage matrix. In: Woessner JF Jr., Howell DS, editors. Joint cartilage degradation: basic and clinical aspects. New York: Marcel Dekker; 1993. p. 159-85.
22. Mort JS, Billington CJ. Articular cartilage and changes in arthritis: matrix degradation. Arthritis Res 2001;3:337-41.
23. Goldring MB. Osteoarthritis and cartilage: the role of cytokines. Curr Rheumatol Rep 2000;2:459-65.
24. Van den Berg WB. Uncoupling of inflammatory and destructive mechanisms in arthritis. Semin Arthritis Rheum 2001;30(5 Suppl 2):7-16.